DXCM

DexCom
DXCM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$32.15B
EV
$32.03B
Shares Outstanding
392.11M
Beta
1.46

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$98.45
P/E 2025E
40.50x
P/Revenue 2025E
6.97x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About DexCom, Inc.

gainify
DXCM

DexCom, Inc.

DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for ...

Sector

Healthcare

Industry

Medical - Devices

CEO

Sayer, Kevin

Employees

10,250

IPO Date

2005-04-14

Headquarters

6340 Sequence Drive, San Diego, California, 92121, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.